Diabetic macular edema: Evidence-based management
Diabetic macular edema (DME) is the most common cause of vision loss in patients with diabetic retinopathy with an increasing prevalence tied to the global epidemic in type 2 diabetes mellitus. Its pathophysiology starts with decreased retinal oxygen tension that manifests as retinal capillary hyper...
Main Authors: | David J Browning, Michael W Stewart, Chong Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2018-01-01
|
Series: | Indian Journal of Ophthalmology |
Subjects: | |
Online Access: | http://www.ijo.in/article.asp?issn=0301-4738;year=2018;volume=66;issue=12;spage=1736;epage=1750;aulast=Browning |
Similar Items
-
Defining Best Practice Standards for the Diagnosis and Management of Diabetic Retinopathy and Diabetic Macular Edema in Latin America
by: Patricio Schlottmann, et al.
Published: (2014-10-01) -
Role of internal limiting membrane peeling for cases of recalcitrant diabetic macular edema
by: Sujit Das, et al.
Published: (2017-01-01) -
Prevalence of and risk factors for diabetic macular edema in a northeastern Chinese population
by: Zhong Lin, et al.
Published: (2022-02-01) -
Treatment before macular grid in patients of diabetic macular edema
by: P S Srilatha, et al.
Published: (2018-01-01) -
Triamcinolona subtenoniana en el edema macular diabético Subtenon triamcinolone in the diabetic macular edema
by: Eddy Mesa Hernández, et al.
Published: (2009-12-01)